Scientists observed that chronic intermittent hypoxia endowed lung cancer with greater metastatic potential, evidenced by increased tumor growth, tumor seeding, and upregulated cancer stem cells-related gene expression in the lungs.
6445212 XX7PBR5A items 1 apa default asc 1
The authors investigated the function of the cancer stem cell marker aldehyde dehydrogenase in retinoic acid cell signaling using an in vitro model of cisplatin resistant non-small cell lung cancer.
6445218 56FEEEKC items 1 apa default asc 1
MacDonagh, L., Santiago, R. M., Gray, S. G., Breen, E., Cuffe, S., Finn, S. P., O’Byrne, K. J., & Barr, M. P. (2021). Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin. Translational Oncology, 14(4), 101025. https://doi.org/10.1016/j.tranon.2021.101025 Cite
Scientists demonstrate that the urinary malate dehydrogenase 2 concentration is higher in early‐stage NSCLC patients than that in controls and may serve as a potential biomarker for the early detection of non‐small cell lung cancer.
6606345 RLLLF4E4 items 1 apa default asc 1
Investigators provide evidence that genetic or pharmacological inhibition of lysine-specific demethylase 4C (KDM4C) impairs tumorigenesis and radioresistance in lung cancer in vitro and in vivo.
[Cell Death & Differentiation]
1254621 SA6AMUY6 items 1 apa default asc 1
Scientists evaluated the antiviral efficacy of enzalutamide in prostate cancer cells, lung cancer cells, human lung organoids and Ad-ACE2-transduced mice.
6445218 AW9LQF3T items 1 apa default asc 1
Li, F., Han, M., Dai, P., Xu, W., He, J., Tao, X., Wu, Y., Tong, X., Xia, X., Guo, W., Zhou, Y., Li, Y., Zhu, Y., Zhang, X., Liu, Z., Aji, R., Cai, X., Li, Y., Qu, D., … Gao, D. (2021). Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide. Nature Communications, 12(1), 866. https://doi.org/10.1038/s41467-021-21171-x Cite
Several studies are currently underway to develop novel diagnostic and prognostic modalities using lung cancer cell-derived exosomes (LCCDEs), and to develop methods of exploiting exosomes for use as efficient drug delivery vehicles. Current status of lung cancer and extensive applicability of LCCDEs are illustrated in this review.
6606345 2VIDJLP9 items 1 apa default asc 1
Investigators found that miR-486-3p was low-expressed in lung cancer. miR-486-3p, which has been found to target XRCC1 and CYP1A1, was regulated by circFLNA. CircFLNA was located in the cytoplasm and had a high expression in lung cancer cells.
[Cancer Gene Therapy]
1254621 Z8Y8DE27 items 1 apa default asc 1
Researchers showed that secretoglobin 3A2 exhibits marked anti-cancer activity against 5 out of 11 of human non-small cell lung cancer cell lines in mouse xenographs, while no effect was observed in 6 of 6 small cell lung cancer cell lines examined.
[Cell Death Discovery]
1254621 D3CQ7GQS items 1 apa default asc 1
Scientists investigated the modulatory role of bone marrow mesenchymal stem cell‐EV‐derived let‐7i and their molecular mechanism in lung cancer progression.
[Journal of Cellular and Molecular Medicine]
1254621 N7XIFUTZ items 1 apa default asc 1
Scientists explored the functional roles of microRNAs in lung cancer patients that were complicated with obstructive sleep apnea-hypopnea involving the deubiquitination enzyme. The miR-320b expression pattern in lung cancer tissues and cells was determined.
[Molecular Therapy-Nucleic Acids]
1254621 EIWFD4RK items 1 apa default asc 1
Researchers integrated the data from a selective drug screen in epithelial and mesenchymal Kras/p53 mutant lung tumor cells with separate datasets including reverse phase protein array and an in vivo shRNA dropout screen.
1254621 HLHDVGL7 items 1 apa default asc 1